Literature DB >> 23251128

Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment.

Ticiana Leal1, Julie E Chang, Minesh Mehta, H Ian Robins.   

Abstract

As therapeutic options and supportive care for the treatment of neoplastic disease have improved, there has been an associated increase in the incidence of leptomeningeal disease. In this review, the clinical presentation, natural history, diagnostic evaluation, and treatment options for this often devastating sequela of solid tumors, lymphoma, and leukemia will be summarized. The therapeutic efficacy of ionizing radiation, systemic agents, and intrathecal drugs will be examined from the existing literature. Additionally the pathophysiology, which in part defines the therapeutic limitations in approaching this patient population, will be discussed in order to assist in individualized clinical decision making.

Entities:  

Year:  2011        PMID: 23251128      PMCID: PMC3523178          DOI: 10.2174/157339411797642597

Source DB:  PubMed          Journal:  Curr Cancer Ther Rev        ISSN: 1573-3947


  60 in total

1.  The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.

Authors:  W Boogerd; M J van den Bent; P J Koehler; J J Heimans; J J van der Sande; N K Aaronson; A A M Hart; J Benraadt; Ch J Vecht
Journal:  Eur J Cancer       Date:  2004-12       Impact factor: 9.162

2.  Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma.

Authors:  R J Ott; M Brada; M A Flower; J W Babich; S R Cherry; B J Deehan
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

3.  Cerebrospinal fluid tumor markers for the diagnosis and management of leptomeningeal metastases.

Authors:  M G Malkin; J B Posner
Journal:  Eur J Cancer Clin Oncol       Date:  1987-01

Review 4.  Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries.

Authors:  W A Bleyer; D G Poplack
Journal:  Semin Oncol       Date:  1985-06       Impact factor: 4.929

Review 5.  Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

Authors:  M Reni; A J Ferreri; N Guha-Thakurta; J Y Blay; S Dell'Oro; P Biron; F H Hochberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

6.  Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.

Authors:  Igor T Gavrilovic; Adília Hormigo; Joachim Yahalom; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

7.  High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.

Authors:  Upendra Hegde; Armando Filie; Richard F Little; John E Janik; Nicole Grant; Seth M Steinberg; Kieron Dunleavy; Elaine S Jaffe; Andrea Abati; Maryalice Stetler-Stevenson; Wyndham H Wilson
Journal:  Blood       Date:  2004-09-09       Impact factor: 22.113

8.  A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.

Authors:  R N Hitchins; D R Bell; R L Woods; J A Levi
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

9.  CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.

Authors:  J E C Bromberg; D A Breems; J Kraan; G Bikker; B van der Holt; P Sillevis Smitt; M J van den Bent; M van't Veer; J W Gratama
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

10.  Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status.

Authors:  M J Glantz; W A Hall; B F Cole; B S Chozick; C M Shannon; L Wahlberg; W Akerley; L Marin; H Choy
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

View more
  52 in total

1.  An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis.

Authors:  Rohit Rao; Santhosh K Sadashiv; Swapna Goday; Dulabh Monga
Journal:  Gastrointest Cancer Res       Date:  2013-05

2.  Diffuse large B-cell lymphoma recurrence presenting as multiple, progressive cranial neuropathies.

Authors:  Abby R Goron; Stephen Devlin; Stacy Schwartz
Journal:  BMJ Case Rep       Date:  2019-07-19

3.  Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.

Authors:  Inna Smalley; Vincent Law; Clayton Wyatt; Brittany Evernden; Bin Fang; John M Koomen; Eric A Welsh; Robert J B Macaulay; Peter A Forsyth; Keiran S M Smalley
Journal:  Clin Cancer Res       Date:  2020-01-10       Impact factor: 12.531

4.  Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.

Authors:  Tavish Nanda; Andrew Yaeh; Cheng-Chia Wu; Ashish Jani; Shumaila Saad; Yasir H Qureshi; Keith A Cauley; Jeraldine Lesser; Simon K Cheng; Steven R Isaacson; Michael B Sisti; Jeffrey N Bruce; Guy M McKhann; Sameer A Sheth; Andrew B Lassman; Tony J C Wang
Journal:  J Neurooncol       Date:  2017-11-23       Impact factor: 4.130

Review 5.  Rare case of pancreatic cancer with leptomeningeal carcinomatosis.

Authors:  In Kyung Yoo; Hong Sik Lee; Chang Duk Kim; Hoon Jai Chun; Yoon Tae Jeen; Bora Keum; Eun Sun Kim; Hyuk Soon Choi; Jae Min Lee; Seung Han Kim; Seung Joo Nam; Jong Jin Hyun
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 6.  Infectious and inflammatory diseases of the central nervous system-the spectrum of imaging findings and differential diagnosis.

Authors:  Joseph M Rozell; Edward Mtui; Yu-Ning Pan; Shan Li
Journal:  Emerg Radiol       Date:  2017-08-22

7.  Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

Authors:  Sherise D Ferguson; Shivani Bindal; Roland L Bassett; Lauren E Haydu; Ian E McCutcheon; Amy B Heimberger; Jing Li; Barbara J O'Brien; Nandita Guha-Thakurta; Michael T Tetzlaff; Hussein Tawbi; Michael A Davies; Isabella C Glitza
Journal:  J Neurooncol       Date:  2019-03-07       Impact factor: 4.130

8.  Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.

Authors:  Amparo Wolf; Bernadine Donahue; Joshua S Silverman; Abraham Chachoua; Jean K Lee; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2017-05-23       Impact factor: 4.130

Review 9.  Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Authors:  Keiran S M Smalley; Inna V Fedorenko; Rajappa S Kenchappa; Solmaz Sahebjam; Peter A Forsyth
Journal:  Int J Cancer       Date:  2016-04-30       Impact factor: 7.396

10.  Pancreatic cancer with leptomeningeal carcinomatosis: case report and literature review.

Authors:  Yuki Ikeda; Makoto Yoshida; Kazuma Ishikawa; Tomohiro Kubo; Kazuyuki Murase; Kohichi Takada; Koji Miyanishi; Junji Kato
Journal:  Int Cancer Conf J       Date:  2020-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.